Jul 2026
Discovery and Preclinical Characterization of I-0436650, a Selective SHP2 Allosteric Inhibitor for RAS-Driven Cancers.
I-0436650 is a low nanomolar allosteric inhibitor of human wild-type SHP2 and strongly inhibits ERK phosphorylation in cells, demonstrating the potential of vertical inhibition strategies.
Alina Ciammaichella, Francesca Puca, Danilo Fabbrini et al.
· Journal of Medicinal Chemist... · 0 citations